![[Toyota Times] Century as a Brand, Lexus as Innovation: All the Details on Toyota's New Project!](https://businessfortnight.com/wp-content/uploads/2025/10/Toyota-Times-Century-as-a-Brand-Lexus-as-Innovation-All-218x150.jpg "[Toyota Times] Century as a Brand, Lexus as Innovation: All the Details on Toyota's New Project!")
CEN Biotech Inc. (OTCQB:CENBF)
WINDSOR, ONTARIO, CANADA, September 16, 2022 /EINPresswire.com/ — CEN Biotech Inc. (“CEN” or the “Company”) (OTCQB: CENBF), a worldwide holding firm centered on the improvement of modern digital media applied sciences, LED lighting expertise and hemp-based merchandise is happy to announce the deliberate launch of its latest expertise product, WordPresto (www.wordpresto.com) on September 28, 2022, at 11:00 AM EDT. This launch occasion will likely be broadcast on each Facebook Live and YouTube dwell and can spotlight WordPresto’s capabilities aiming to revolutionize the internet design market and to deal with the wants of scalable and reasonably priced internet design.
Date: September 28, 2022
Time: 11:00 AM EDT / 8:00 AM PDT
Location: www.wordpresto.com (Links to Facebook and YouTube dwell occasions from the residence web page)
WordPresto is a each a product and repair that seeks to offer individuals with a personalized internet design expertise that makes use of PhrasePress as the core content material administration system as its internet platform. WordPresto goals to offer interactive and customised internet design applied sciences and companies coupled with reasonably priced ongoing help and upkeep. Our staff goals to work from the floor as much as rapidly and affordably create an eloquent web site that provides customers a customized feel and appear. With WordPresto, all you want to do is talk your wants, present ongoing suggestions and let our consultants do the relaxation. It begins with deciding on a web site bundle that most accurately fits your organization’s wants based mostly on the business, general targets and goals, and different advertising efforts which are in place. Each web site bundle contains picture and software program licensing, skilled design and improvement, updates and safety patches, enterprise internet hosting, venture administration, and ongoing help and upkeep.
The launch occasion will likely be hosted by Larry Lehoux, the Company’s President, and Chief Technology Officer, who states “WordPresto is the first scheduled launch of a new line of products which are in the process of being developed by CEN. We are very excited to bring forth and continue seeking to develop leading consumer and business-focused products that utilize Artificial Intelligence-based technologies designed to make website development and maintenance more efficient and affordable. CEN has fully embraced the power of Artificial Intelligence and intends to design a series of products and services that utilize A.I. technologies to make everyday life easier, more efficient informative and entertaining.”
About CEN Biotech Inc.
CEN Biotech, Inc. is a worldwide holding firm centered on the improvement of digital media and LED lighting expertise and hemp-based merchandise. For additional data on the Company, please go to our web site at www.cenbiotechinc.com. Information about the Company can be discovered on the Securities and Exchange Commission’s EDGAR website below the Issuer Profile of “CEN Biotech Inc.”
Cautionary Note Regarding Forward Looking Statements
This press launch incorporates “forward-looking” statements. In specific, the phrases “believe,” “may,” “could,” “should,” “expect,” “anticipate,” “estimate,” “project,” “propose,” “plan,” “intend,” and comparable conditional phrases and expressions are meant to establish forward-looking statements. Any statements made on this press launch about an motion, occasion or improvement, are forward-looking. These forward-looking statements are solely predictions and are topic to sure dangers, uncertainties, and assumptions, many of which can be past the management of CEN, that might trigger precise outcomes to vary from these in the forward-looking statements. Accordingly, you shouldn’t place undue reliance on these forward-looking statements. Although CEN believes that the expectations mirrored in the forward-looking statements are affordable, it may give no assurance that its forward-looking statements will show to be appropriate. Potential dangers embody such components as the incapability to enter into agreements with events with whom we’re in discussions, components that can not be predicted with certainty, in addition to further dangers and uncertainties which are recognized and described in CEN’s stories filed with the Securities and Exchange Commission (the “SEC”). Investors are cautioned that any forward-looking statements are usually not ensures of future efficiency and precise outcomes or developments could differ materially from these projected. Actual outcomes could differ materially from the forward-looking statements on this press launch. Statements made herein are as of the date of this press launch and shouldn’t be relied upon as of any subsequent date. CEN doesn’t undertake, and it particularly disclaims, any obligation to replace any forward-looking statements to mirror occurrences, developments, occasions or circumstances after the date of such assertion besides as required in accordance with relevant legal guidelines.
Press Contact
Brian S. Payne
Chief Executive Officer
CEN Biotech Inc.
Phone: (519) 981-0970
Email: [email protected]
Email: [email protected]
Brian Payne
CEN Biotech Inc.
e-mail us right here
